|
Volumn 53, Issue 1, 2005, Pages 61-66
|
Development and assessment of indicators of rheumatoid arthritis severity: Results of a Delphi panel
|
Author keywords
Delphi panel; Disease severity; Rheumatoid arthritis
|
Indexed keywords
ADALIMUMAB;
ANTIRHEUMATIC AGENT;
AZATHIOPRINE;
C REACTIVE PROTEIN;
CYCLIC CITRULLINATED PEPTIDE ANTIBODY;
CYCLOSPORIN;
ETANERCEPT;
GLUCOCORTICOID;
GOLD;
HLA ANTIGEN;
HYDROXYCHLOROQUINE;
INFLIXIMAB;
LEFLUNOMIDE;
METHOTREXATE;
RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;
RHEUMATOID FACTOR;
SALAZOSULFAPYRIDINE;
BONE EROSION;
CLINICAL FEATURE;
DISEASE SEVERITY;
EMPLOYMENT;
ERYTHROCYTE SEDIMENTATION RATE;
FELTY SYNDROME;
FUNCTIONAL ASSESSMENT;
HUMAN;
JOINT STIFFNESS;
LABORATORY TEST;
LUNG NODULE;
MEDICAL RECORD;
QUESTIONNAIRE;
RADIOLOGY;
REVIEW;
RHEUMATOID ARTHRITIS;
RHEUMATOLOGY;
SUBCUTANEOUS NODULE;
SUBLUXATION;
VASCULITIS;
WALKING AID;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
DELPHI TECHNIQUE;
HUMANS;
MEDICAL RECORDS;
RHEUMATOLOGY;
SEVERITY OF ILLNESS INDEX;
|
EID: 13444310434
PISSN: 21514658
EISSN: None
Source Type: Journal
DOI: 10.1002/art.20925 Document Type: Review |
Times cited : (39)
|
References (13)
|